Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening.

Journal of gynecologic oncology - 1 Nov 2024

Cho Eun Hye, Park Min-Seung, Woo Hee-Yeon, Park Hyosoon, Kwon Min-Jung

Abstract excerpt

OBJECTIVE: High-risk human papillomavirus (HR-HPV) infection is a leading cause of cervical cancer, of which human papillomavirus (HPV)-16 and HPV-18 account for about 70% of cases. Since HPV infection is common, it is important to focus on the HPV genotypes that pose the highest risk for effective cervical cancer screening. In this study, we evaluated the clinical usefulness of HPV-16/HPV-18 genotyping for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer
Share to Genotyping Techniques

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Human papillomavirus 16

Share to Human papillomavirus 18

Share to Papillomavirus Infections

Share to Predictive Value of Tests

Share to Uterine Cervical Dysplasia

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 38522949
DOI: 10.3802/jgo.2024.35.e72
PMCID: PMC11543248

Genes

AR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening.PMID 38522949Read ↗

Diagnostic value of high-risk HPV other than type 16/18 in high-grade cervical neoplasia among cytology-negative women: A multicenter retrospective study.Semantic proximity Read ↗

HPV-specific risk assessment of cervical cytological abnormalitiesSemantic proximity Read ↗

The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern ChinaSemantic proximity Read ↗

Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies.Semantic proximity Read ↗

High-risk HPV DNA testing and HPV-16/18 genotyping: what is the clinical application?Semantic proximity Read ↗

The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.Semantic proximity Read ↗

Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.Semantic proximity Read ↗

The Clinical Utility of Extended High-Risk HPV Genotyping in Women With ASC-US Cytology.Semantic proximity Read ↗

Clinical significance of human papillomavirus genotyping.Semantic proximity Read ↗

Comprehensive overview of genotype distribution and prevalence of human papillomavirus in cervical lesionsSemantic proximity Read ↗

Investigating the link between HPV genotypes and cervical abnormality incidence in women with HPV infections: insights from a leading referral centreSemantic proximity Read ↗

Risk stratification for cervical neoplasia using extended high-risk HPV genotyping in women with ASC-US cytology: A large retrospective study from China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.